Saturday 17 October 2026
Export MDXH’s income statement to Excel — free account
MDxHealth SA
MDXH Healthcare Diagnostics & Research
MDxHealth SA’s revenue for fiscal 2025 (year ended December 2025) was $107.9 million, up 19.8% from fiscal 2024. In the quarter to June 2026, revenue grew 12.0%, EPS fell 15.8%, free cash flow fell 200.2% and total debt rose 26.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
0.21
0.39
−65.00%
Follow MDXH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | 4 | 4 | 4 |
+8 more TTM periods Free account |
| 238.67% | 491.05% | (2,401.75%) | (807.44%) | ||
| (27.38%) | (20.86%) | (21.61%) | (22.62%) | ||
ROIC |
(23.77%) | (30.97%) | (25.09%) | (24.54%) | |
Return on Tangible Assets |
(404.34%) | (113.57%) | (377.87%) | (282.31%) | |
Average Days of Receivables |
47.46 | 46.53 | 49.04 | 66.71 | |
Free Cash Flow per Share |
(0.11) | (0.04) | (0.07) | (0.14) | |
Free Cash Flow |
(6.02) | (2.09) | (3.35) | (6.98) | |
Capital Expenditures |
(0.72) | (1.04) | (1.16) | (1.29) | |
| Other line items | |||||
Cash ROIC |
(6.48%) | (1.65%) | (3.29%) | (6.36%) | |
Accounts Receivable Turnover |
7.49 | 7.51 | 7.50 | 6.01 | |
Accounts Payable Turnover |
4.88 | 4.25 | 4.38 | 3.70 | |
Inventory Turnover |
8.37 | 7.79 | 7.56 | 7.00 | |
Average Days of Payables |
91.39 | 105.71 | 93.96 | 93.61 | |
Days of Inventory on Hand |
55.63 | 64.53 | 61.31 | 60.64 | |
Tax Rate |
0.00 | 0.00 | (0.04) | 0.01 | |
Research and Development Expense of Revenue |
8.82% | 9.50% | 10.33% | 10.01% | |
Selling, General and Administrative Expense of Revenue |
68.80% | 67.08% | 64.17% | 65.77% | |
Share Based Compensation of Revenue |
2.01% | 2.13% | 2.02% | 2.19% | |
Interest Coverage |
(0.78) | (0.79) | (0.91) | (0.96) | |
Operating CF/Net income |
0.14 | 0.03 | 0.07 | 0.16 | |
Depreciation/Fixed assets |
2.63 | 2.07 | 1.90 | 1.65 | |
Capex/Depreciation |
(0.08) | (0.11) | (0.13) | (0.14) | |
Revenue per Share |
2.19 | 2.14 | 2.19 | 1.99 | |
Operating CF per Share |
(0.10) | (0.02) | (0.04) | (0.11) | |
Capex per Share |
(0.01) | (0.02) | (0.02) | (0.03) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates